Abstract

Recent advances in cytokine research have revolutionized the understanding and treatment of chronic inflammatory diseases. Cytokines, key regulators of immune responses, play a pivotal role in the pathogenesis of conditions such as rheumatoid arthritis, inflammatory bowel disease, and psoriasis. Targeted biologic therapies that inhibit specific cytokines have significantly improved clinical outcomes, offering personalized treatment options and enhancing quality of life for patients. This article reviews the current landscape of cytokine-targeted therapies, discusses emerging therapeutic strategies, and highlights the challenges and future directions in the field.